Inozyme Pharma, Inc.

Q1 2024 13F Holders

Symbol
INZY
CUSIP
45790W108
Type
Equity
Class
COM
Num filings
96
Total reported value, excl. options
$384 M
Manager Report Date Value ($000) Shares Option Type